Loading...
•
Sep 30, 2023
Stepan Q3 2023 Earnings Report
Stepan's third quarter results reflected gradual volume, adjusted EBITDA and adjusted net income growth compared to the second quarter of 2023, but were down year-over-year.
Key Takeaways
Stepan Company reported a decrease in net income for Q3 2023, with $12.6 million compared to $39.4 million in the prior year. The decline was influenced by lower sales volume and unit margins in the Surfactant and Specialty Product segments. However, there was sequential growth versus the second quarter of 2023, led by higher Rigid Polyols demand and new contracted volume for low 1,4 dioxane products.
Reported net income was $12.6 million, or $0.55 per diluted share, versus $39.4 million, or $1.71 per diluted share, in the prior year.
Surfactant operating income was $15.4 million versus $39.0 million in the prior year, driven by a 7% decline in global sales volume and lower unit margins.
Polymer operating income was $21.8 million versus $31.9 million in the prior year, primarily due to a 12% decline in global sales volume.
Specialty Product operating income was $2.4 million versus $9.7 million in the prior year, attributable to lower unit margins and sales volume within the medium chain triglycerides (MCT) product line.
Stepan
Stepan
Stepan Revenue by Segment
Revenue by Segment
Surfactants Revenue
CapyFin.comPolymers Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
The company anticipates challenges in Q4 2023, similar to the first nine months, including destocking in the agricultural end market and low seasonal demand for Rigid Polyols. They expect to reduce inventory further by year-end and approach the end of their high capital spending phase. Looking to 2024, they anticipate improved volumes and margins due to recovery in Rigid Polyols demand, Surfactant volume growth from new contracts, and lower raw material costs. The company is expanding cost reduction activities and expects to deliver $50 million in pre-tax savings in 2024.
Positive Outlook
- Volumes and margins will improve due to continued recovery in Rigid Polyols demand.
- Growth in Surfactant volume driven by new contracted business.
- Lower raw material costs are expected.
- Cost reduction activities are expected to deliver $50 million in pre-tax savings in 2024.
- Strategic initiatives and cost reductions should position the company to deliver earnings growth and positive free cash flow in 2024.
Challenges Ahead
- The fourth quarter of 2023 will face challenges similar to those experienced during the first nine months.
- Continued destocking within the agricultural end market is expected.
- Normal low seasonal demand for Rigid Polyols is anticipated.
- Future inflation.
- Increased expenses associated with the planned commissioning of our new Pasadena alkoxylation assets.
Revenue & Expenses
Visualization of income flow from segment revenue to net income